PRESENTATION

Q2 2021 — Earnings presentation

Q2 2021PDF · 16 pages290 KB
2021
Second Quarter
Earnings
(Unaudited)
July 27, 2021
Photo reference: The sample name is “Polymeric Netting with Ribbons.” The samples have use in absorbent articles
for Health Care and Consumer products.

-- 1 of 16 --

22
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Events
2021 Earnings Calls
Q3 October 26

-- 2 of 16 --

33
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Forward looking statement
This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and
uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will,"
"should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance
or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political,
regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change
affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the
coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits
concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of
jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual
Report on Form 10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and
customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw
materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by
natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP)
system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances,
divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring;
(11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may
affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14)
tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different
results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk
Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-
K. The information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements
contained in this presentation as a result of new information or future events or developments.
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s July 27, 2021, press release for descriptions of non-GAAP financial measures such
free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust
for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-
GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release.
Note on non-GAAP financial measures

-- 3 of 16 --

44
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 … continued strong growth and execution
Vision
• Broad-based organic growth across all business groups and geographic areas
• Strong growth and operating rigor driving increased earnings, margins and robust cash flow
• Global economic recovery continues to improve, though uncertainty remains from COVID-19
• Ongoing strength in end markets including home improvement, oral care and industrial; health care elective
procedure volumes increasing
• Supply chain, raw material and logistics headwinds expected to persist through 2021; declining pandemic-
related demand for disposable respirators
• Prioritizing investments in growth, productivity and sustainability
• Updating full-year 2021 guidance

-- 4 of 16 --

55
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 summary
21.4%
year-on-year
Organic local-
currency growth
22.0%
+2.4 ppts year-on-year
Adjusted operating
margin
$2.59
+44% year-on-year
Adjusted earnings
per share
Sales of $8.9B, up 24.7% year-on-year
Organic sales growth across all business groups led by
Transportation & Electronics and Health Care
Accelerating investments in growth platforms including
automotive electrification, air quality, home improvement, and
biopharma filtration
Health care respirator demand slowing, shifting output to
industrial and consumer end markets; adjusting manufacturing
production volumes
Strong operational execution despite significant year-on-year
increase in raw materials and logistics costs
Delivering strong cash flow and continuing to strengthen capital
structure and financial flexibility

-- 5 of 16 --

66
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 adjusted operating margin and EPS
+9.0%
Adjusted
Operating
Income Margin
Adjusted
Earnings Per
Share
Q2 2020 19.6% $1.81
Organic volume/productivity
and other +4.1% +$0.89
Strong organic volume growth and productivity; benefits from restructuring
actions; application of Brazilian Supreme Court social tax ruling (+1.0%; +$0.12);
increases in certain legal reserves and ongoing legal costs
Price/raw material -1.4% -$0.17 Selling price increases more than offset by higher raw materials and logistics costs
Divestitures* -0.1% -$0.02 Drug delivery divestiture (May 2020)
FX -0.2% +$0.08 Net of hedge impact; full-year 2021 FX benefit of approximately $0.15 per share,
remains unchanged
Other expense/income NA +$0.06 Primarily non-operating pension benefit (+$0.05)
Tax rate** NA -$0.03 Adjusted Q2 2021 tax rate 21.5% versus 20.7% in prior year; full-year 2021 tax rate
range of 20% to 21%, remains unchanged
Shares outstanding NA -$0.03 Average diluted shares up 1%
Q2 2021 22.0% $2.59
* Includes impact of lost income from divested businesses.
** The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 6 of 16 --

77
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 cash flow and balance sheet
Proactive balance sheet management
• Net debt of $12.7B, down $3.5B, or 22% year-on-year
Adjusted free cash flow conversion
• Q2: 103%, down 44 ppts; YTD: 94%, down 13 ppts
• Q2 and YTD year-on-year decline in conversion of 37
and 17 ppts, respectively, due to timing of prior year
income tax payment
Capital expenditures
• Q2: $394M; YTD $704M
• FY 2021: $1.8B to $2.0B
Cash returned to shareholders
• Dividends: Q2 $858M; YTD $1.7B
• Gross share repurchases: Q2 $503M; YTD $734M
$1.6B
+2% year-on-year
Adjusted free cash
flow
103%
-44 ppts year-on-year
Adjusted free cash
flow conversion
$1.4B
+61% year-on-year
Cash returned to
shareholders

-- 7 of 16 --

88
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 Business Group performance
Organic
Growth
Segment
Operating
Margin Commentary
Safety &
Industrial +17.6% 22.1%
• Continued end-market strength (industrial, automotive, electronics, construction) driving growth in
autobody repair, roofing granules, abrasives, industrial adhesives and tapes, and electrical OEM/MRO
• Disposable respirator sales up 3% organically year-on-year; however, declined 11% sequentially
• Operating margins -1.3 ppts year-on-year; increases in raw materials, logistics and legal costs partially
offset by sales growth
Transportation
& Electronics +24.2% 22.0%
• Organic growth led by automotive OEM; continued strength in semiconductor, factory automation and
consumer electronics (TVs/tablets)
• Operating margins +3.4 ppts year-on-year; improvement due to sales growth, partially offset by rising
raw materials and logistics costs
Health Care +23.2% 25.3%
• Organic growth led by oral care due to higher patient visits; continued improvement in medical solutions
due to rising elective procedure volumes; food safety benefited as food services activity returned
• Operating margins +8.8 ppts year-on-year; improvement due to sales growth, partially offset by rising
raw materials and logistics costs
Consumer +17.8% 21.0%
• Continued strength in home improvement and home cleaning; improving office and stationery demand
driven by return-to-school and workplace trends
• Operating margins -1.6 ppts year-on-year; increases in raw materials, logistics, outsourced hardgoods
manufacturing costs, and investments in advertising/merchandising, partially offset by sales growth

-- 8 of 16 --

99
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Updating 2021 planning estimates
Second-half 2021 expectations Third quarter items of note
• Global macroeconomic and end-market recovery continues,
but remain fluid and uneven
• Improving health care elective procedure volumes; and
return-to-workplace/school trends
• Decline in pandemic-related disposable respirator demand of
$100-300M year-on-year
• Continued semiconductor chip supply constraints negatively
impacting electronics & auto OEM production volumes
• Raw materials and logistics inflation persists; now expect full-
year 2021 headwind of $0.65-$0.80 per share vs. $0.30-
$0.50, prior; $0.40-$0.55 per share in the second half
• Restructuring program on track, anticipate pre-tax
restructuring charge of $60-110M
• Maintaining strong execution and operating rigor while
continuing to invest in growth, productivity and sustainability
• End-market trends:
• Health care elective procedure volumes to increase
• Home improvement remains strong
• Return-to-school and workplace trends improving
• Smartphone shipments down HSD year-on-year
• Global car & light truck builds down 3% year-on-year
• Decline in pandemic-related disposable respirator demand of
$50-100M year-on-year ($100-150M sequentially)
• Expect year-on-year operating margin headwind of 50-100
bps from raw materials/logistics costs net of selling price
• Pre-tax restructuring charge of $50-75M
• Increase in legal defense costs year-on-year
• Higher investments in growth, productivity and sustainability
Organic local-currency growth
6% to 9% vs.
3% to 6%, prior
Earnings per share
$9.70 to $10.10 vs.
$9.20 to $9.70, prior
Free cash flow conversion
90% to 100% vs.
95% to 105%, prior

-- 9 of 16 --

10	10
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q&A
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President &
Chief Financial Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 10 of 16 --

11	11
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Appendix

-- 11 of 16 --

12	12
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 P&L
($M)
Q2
2020
Q2
2021 Change
Sales $7,176 $8,950 +24.7%
Gross profit $3,371 $4,231 +25.5%
% to sales 47.0% 47.3% +0.3 pts
SG&A $1,594 $1,746 +9.6%
% to sales 22.2% 19.6% -2.6 pts
R&D & related $424 $514 +21.0%
% to sales 5.9% 5.7% -0.2 pts
Gain on sale of businesses ($387) ---- NM
% to sales (5.4%) ---- NM
Operating income $1,740 $1,971 +13.2%
% to sales 24.3% 22.0% -2.3 pts
Net income $1,306 $1,524 +16.7%
GAAP earnings per share $2.25 $2.59 +15.1%

-- 12 of 16 --

13	13
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Q2 2021 sales recap
Americas EMEA APAC Worldwide
Organic volume +25.3% +19.8% +15.9% +21.3%
Price +0.3% +0.3% -0.5% +0.1%
Organic local-currency +25.6% +20.1% +15.4% +21.4%
Acquisitions/Divestitures -0.7% -1.6% ---- -0.7%
FX +1.2% +10.2% +4.8% +4.0%
Total growth +26.1% +28.7% +20.2% +24.7%
U.S. Canada Mexico Brazil China/HK Japan
Organic local-currency +21.9% +36.6% +59.8% +54.4% +12.3% +12.2%

-- 13 of 16 --

14	14
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Business segment information
($M) Net Sales Q2 2021 Sales Growth
Organic local-currency
by Geographic Area
Business Segment Operating
Income/Adjusted Operating
Income*
Business Segment
Operating
Margin/Adjusted
Operating Margin*
Business groups
Q2
2020
Q2
2021
Organic
local-
currency FX M&A
Total
Sales
Change Americas
Asia
Pacific EMEA
Q2
2020
Q2
2021
Percent
change
Q2
2020
Q2
2021
Safety & Industrial $2,657 $3,254 17.6% 4.8% 0.0% 22.4% 21% 18% 10% $623 $718 15.3% 23.4% 22.1%
Transportation &
Electronics $1,937 $2,482 24.2% 3.9% 0.0% 28.1% 34% 17% 39% $360 $546 51.6% 18.6% 22.0%
Health Care $1,823 $2,278 23.2% 4.3% -2.6% 24.9% 25% 14% 26% $301 $576 91.9% 16.5% 25.3%
Consumer $1,231 $1,482 17.8% 2.6% 0.0% 20.4% 20% 9% 19% $278 $311 11.8% 22.6% 21.0%
Elimination of Dual
Credit ($473) ($547) ($119) ($138)
Total Operating
Business Segment $1,443 $2,013
Corporate &
Unallocated $1 $1 ($35) ($42)
Total $7,176 $8,950 21.4% 4.0% -0.7% 24.7% 25.6% 15.4% 20.1% $1,408 $1,971 39.9% 19.6% 22.0%
* “Corporate and Unallocated” and “Total” provided on an adjusted basis
Organic local-currency = organic volume + price

-- 14 of 16 --

15	15
2021 Q2 Earnings – July 27, 2021. All rights reserved.
Additional sales detail
($M) Net Sales
Business groups Q2 2020 Q2 2021
Abrasives 242 353
Automotive Aftermarket 202 313
Closure and Masking Systems 235 254
Electrical Materials 251 319
Industrial Adhesives & Tapes 545 761
Personal Safety 1,095 1,133
Roofing Granules 86 121
Other Safety & Industrial 1 0
Total Safety & Industrial Business Group 2,657 3,254
Advanced Materials 236 304
Automotive & Aerospace 268 469
Commercial Solutions 327 454
Electronics 884 998
Transportation Safety 222 259
Other Transportation & Electronics 0 (2)
Total Transportation & Electronics Business Group 1,937 2,482
($M) Net Sales
Business groups Q2 2020 Q2 2021
Drug Delivery 41 0
Food Safety 78 95
Health Information Systems 276 299
Medical Solutions 1,067 1,275
Oral Care 144 364
Separation & Purification Sciences 216 248
Other Health Care 1 (3)
Total Health Care Business Group 1,823 2,278
Consumer Health & Safety 120 163
Home Care 257 272
Home Improvement 564 666
Stationery & Office 257 352
Other Consumer 33 29
Total Consumer Business Group 1,231 1,482
Corporate & Unallocated 1 1
Elimination of Dual Credit (473) (547)
Total 7,176 8,950

-- 15 of 16 --



-- 16 of 16 --